Metabolic Technologies, Inc. (MTI), an esteemed research and product development company located in Ames, Iowa, and TSI Health Sciences, the Missoula, Montana-based, high-end ingredient manufacturing company specializing in global sales and marketing, are combining their efforts to bring more innovative proprietary products to the marketplace.
MTI is a successful research-driven company that develops credible, safe and effective nutritional products. MTI’s first product, beta-hydroxy-beta-methylbutyrate (HMB), has become one of the most well-known and most effective nutritional supplements available on the market today. With numerous published studies, HMB has been proven to help both casual and competitive athletes improve their strength and endurance as well as having applications in general health and medical nutrition, and has also been proven to be clinically safe.
HMB is one example of the company’s commitment to creating and manufacturing products that are effective and safe to use. For every product researched and developed, MTI sets standards that meet or exceed the highest industry standards and supports its products with research and testing conducted at leading universities.
TSI Health Sciences has evolved throughout the last decade to excel in superior manufacturing processes and assurances and become a leading developer and producer of nutraceutical, food and pharmaceutical products sold in over 30 countries. The company offers products and services in two primary areas—integrated high-quality supply chain value, consisting of manufacturing capabilities ranging from ingredient production, drum-to-hopper formulations, and production of the final finished dose product—and ingredient innovation, leading to the discovery and launch of safe and effective formulations that helps create innovative customer products to improve the quality of life for consumers globally.
“The strategic partnership between MTI and TSI allows both parties to develop and commercialize products with shared resources, talent and vision, leading to greater long-term business value for both companies, as well as bringing a vast range of new, innovative ingredients to the marketplace faster and more effectively,” said Larry Kolb, TSI Health Sciences U.S. operations president.
“The goals for MTI and TSI are to collaborate and create clinically tested and proven ingredients protected by manufacturing expertise, knowhow or process patents, composition and use patents, brands and trademarks,” said Shawn Baier, MTI chief operating officer.